Five drugs, including two Novartis therapies, win EMA endorsement

Five drugs, including two Novartis therapies, win EMA endorsement

Source: 
Endpoints
snippet: 

As is custom, an EMA panel on Friday issued its weekly recommendations on marketing applications submitted by drug developers. This week, the agency backed the use of five new therapies — including two Novartis drugs — but issued no negative reviews.